Repurposing CD8⁺ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

Shashi Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer

Economics, Econometrics and Finance

Research output: Contribution to journal › Review article › peer-review

10 Citations (Scopus)

1 results
- Relevance

Repurposing COVID‑19 immune response for cancer therapy
Shashi, G.
9/15/20
1 item of Media coverage
Press/Media: Research